_version_ 1784659956136411136
author Bertrums, Eline J.M.
Zwaan, C. Michel
Hasegawa, Daisuke
de Haas, Valerie
Reinhardt, Dirk N.
Locatelli, Franco
de Moerloose, Barbara
Dworzak, Michael
Buijs, Arjan
Smisek, Petr
Kolenova, Alexandra
Pronk, Cornelis Jan
Klusmann, Jan-Henning
Carboné, Ana
Ferster, Alina
Antoniou, Evangelia
Meshinchi, Soheil
Raimondi, Susana C.
Niemeyer, Charlotte M.
Hasle, Henrik
van den Heuvel-Eibrink, Marry M.
Goemans, Bianca F.
author_facet Bertrums, Eline J.M.
Zwaan, C. Michel
Hasegawa, Daisuke
de Haas, Valerie
Reinhardt, Dirk N.
Locatelli, Franco
de Moerloose, Barbara
Dworzak, Michael
Buijs, Arjan
Smisek, Petr
Kolenova, Alexandra
Pronk, Cornelis Jan
Klusmann, Jan-Henning
Carboné, Ana
Ferster, Alina
Antoniou, Evangelia
Meshinchi, Soheil
Raimondi, Susana C.
Niemeyer, Charlotte M.
Hasle, Henrik
van den Heuvel-Eibrink, Marry M.
Goemans, Bianca F.
author_sort Bertrums, Eline J.M.
collection PubMed
description
format Online
Article
Text
id pubmed-8883540
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Fondazione Ferrata Storti
record_format MEDLINE/PubMed
spelling pubmed-88835402022-03-18 Guideline for management of non-Down syndrome neonates with a myeloproliferative disease on behalf of the I-BFM AML Study Group and EWOG-MDS^ Bertrums, Eline J.M. Zwaan, C. Michel Hasegawa, Daisuke de Haas, Valerie Reinhardt, Dirk N. Locatelli, Franco de Moerloose, Barbara Dworzak, Michael Buijs, Arjan Smisek, Petr Kolenova, Alexandra Pronk, Cornelis Jan Klusmann, Jan-Henning Carboné, Ana Ferster, Alina Antoniou, Evangelia Meshinchi, Soheil Raimondi, Susana C. Niemeyer, Charlotte M. Hasle, Henrik van den Heuvel-Eibrink, Marry M. Goemans, Bianca F. Haematologica Letters to the Editor Fondazione Ferrata Storti 2021-12-02 /pmc/articles/PMC8883540/ /pubmed/34854279 http://dx.doi.org/10.3324/haematol.2021.279507 Text en Copyright© 2022 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Letters to the Editor
Bertrums, Eline J.M.
Zwaan, C. Michel
Hasegawa, Daisuke
de Haas, Valerie
Reinhardt, Dirk N.
Locatelli, Franco
de Moerloose, Barbara
Dworzak, Michael
Buijs, Arjan
Smisek, Petr
Kolenova, Alexandra
Pronk, Cornelis Jan
Klusmann, Jan-Henning
Carboné, Ana
Ferster, Alina
Antoniou, Evangelia
Meshinchi, Soheil
Raimondi, Susana C.
Niemeyer, Charlotte M.
Hasle, Henrik
van den Heuvel-Eibrink, Marry M.
Goemans, Bianca F.
Guideline for management of non-Down syndrome neonates with a myeloproliferative disease on behalf of the I-BFM AML Study Group and EWOG-MDS^
title Guideline for management of non-Down syndrome neonates with a myeloproliferative disease on behalf of the I-BFM AML Study Group and EWOG-MDS^
title_full Guideline for management of non-Down syndrome neonates with a myeloproliferative disease on behalf of the I-BFM AML Study Group and EWOG-MDS^
title_fullStr Guideline for management of non-Down syndrome neonates with a myeloproliferative disease on behalf of the I-BFM AML Study Group and EWOG-MDS^
title_full_unstemmed Guideline for management of non-Down syndrome neonates with a myeloproliferative disease on behalf of the I-BFM AML Study Group and EWOG-MDS^
title_short Guideline for management of non-Down syndrome neonates with a myeloproliferative disease on behalf of the I-BFM AML Study Group and EWOG-MDS^
title_sort guideline for management of non-down syndrome neonates with a myeloproliferative disease on behalf of the i-bfm aml study group and ewog-mds^
topic Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8883540/
https://www.ncbi.nlm.nih.gov/pubmed/34854279
http://dx.doi.org/10.3324/haematol.2021.279507
work_keys_str_mv AT bertrumselinejm guidelineformanagementofnondownsyndromeneonateswithamyeloproliferativediseaseonbehalfoftheibfmamlstudygroupandewogmds
AT zwaancmichel guidelineformanagementofnondownsyndromeneonateswithamyeloproliferativediseaseonbehalfoftheibfmamlstudygroupandewogmds
AT hasegawadaisuke guidelineformanagementofnondownsyndromeneonateswithamyeloproliferativediseaseonbehalfoftheibfmamlstudygroupandewogmds
AT dehaasvalerie guidelineformanagementofnondownsyndromeneonateswithamyeloproliferativediseaseonbehalfoftheibfmamlstudygroupandewogmds
AT reinhardtdirkn guidelineformanagementofnondownsyndromeneonateswithamyeloproliferativediseaseonbehalfoftheibfmamlstudygroupandewogmds
AT locatellifranco guidelineformanagementofnondownsyndromeneonateswithamyeloproliferativediseaseonbehalfoftheibfmamlstudygroupandewogmds
AT demoerloosebarbara guidelineformanagementofnondownsyndromeneonateswithamyeloproliferativediseaseonbehalfoftheibfmamlstudygroupandewogmds
AT dworzakmichael guidelineformanagementofnondownsyndromeneonateswithamyeloproliferativediseaseonbehalfoftheibfmamlstudygroupandewogmds
AT buijsarjan guidelineformanagementofnondownsyndromeneonateswithamyeloproliferativediseaseonbehalfoftheibfmamlstudygroupandewogmds
AT smisekpetr guidelineformanagementofnondownsyndromeneonateswithamyeloproliferativediseaseonbehalfoftheibfmamlstudygroupandewogmds
AT kolenovaalexandra guidelineformanagementofnondownsyndromeneonateswithamyeloproliferativediseaseonbehalfoftheibfmamlstudygroupandewogmds
AT pronkcornelisjan guidelineformanagementofnondownsyndromeneonateswithamyeloproliferativediseaseonbehalfoftheibfmamlstudygroupandewogmds
AT klusmannjanhenning guidelineformanagementofnondownsyndromeneonateswithamyeloproliferativediseaseonbehalfoftheibfmamlstudygroupandewogmds
AT carboneana guidelineformanagementofnondownsyndromeneonateswithamyeloproliferativediseaseonbehalfoftheibfmamlstudygroupandewogmds
AT fersteralina guidelineformanagementofnondownsyndromeneonateswithamyeloproliferativediseaseonbehalfoftheibfmamlstudygroupandewogmds
AT antoniouevangelia guidelineformanagementofnondownsyndromeneonateswithamyeloproliferativediseaseonbehalfoftheibfmamlstudygroupandewogmds
AT meshinchisoheil guidelineformanagementofnondownsyndromeneonateswithamyeloproliferativediseaseonbehalfoftheibfmamlstudygroupandewogmds
AT raimondisusanac guidelineformanagementofnondownsyndromeneonateswithamyeloproliferativediseaseonbehalfoftheibfmamlstudygroupandewogmds
AT niemeyercharlottem guidelineformanagementofnondownsyndromeneonateswithamyeloproliferativediseaseonbehalfoftheibfmamlstudygroupandewogmds
AT haslehenrik guidelineformanagementofnondownsyndromeneonateswithamyeloproliferativediseaseonbehalfoftheibfmamlstudygroupandewogmds
AT vandenheuveleibrinkmarrym guidelineformanagementofnondownsyndromeneonateswithamyeloproliferativediseaseonbehalfoftheibfmamlstudygroupandewogmds
AT goemansbiancaf guidelineformanagementofnondownsyndromeneonateswithamyeloproliferativediseaseonbehalfoftheibfmamlstudygroupandewogmds